These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 7801008

  • 1. [A case from practice (312). Chronic active hepatitis B--nonresponder to interferon therapy].
    Stoll A.
    Praxis (Bern 1994); 1994 Nov 29; 83(48):1359-60. PubMed ID: 7801008
    [No Abstract] [Full Text] [Related]

  • 2. Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis.
    Georgetson MJ, Yarze JC, Lalos AT, Webster GF, Martin P.
    Am J Gastroenterol; 1993 Oct 29; 88(10):1756-8. PubMed ID: 8213720
    [Abstract] [Full Text] [Related]

  • 3. [Interferon therapy of chronic hepatitis B in children].
    Pilette C, Calès P.
    Gastroenterol Clin Biol; 1995 Jan 29; 19(1):139-42. PubMed ID: 7720983
    [No Abstract] [Full Text] [Related]

  • 4. [Interferon is useful in the treatment of chronic hepatitis B].
    Vuoristo M.
    Duodecim; 1991 Jan 29; 107(13):1087-90. PubMed ID: 1365335
    [No Abstract] [Full Text] [Related]

  • 5. [Interferon therapy in chronic active viral hepatitis].
    Lengyel G, Fehér J.
    Orv Hetil; 1995 Jan 01; 136(1):3-7. PubMed ID: 7531317
    [Abstract] [Full Text] [Related]

  • 6. [Therapy noncompliance in chronic viral hepatitis--standard therapy, prognostic parameters, treatment strategy].
    Hopf U.
    Praxis (Bern 1994); 1997 Jan 21; 86(4):83-5. PubMed ID: 9064723
    [No Abstract] [Full Text] [Related]

  • 7. [Histologic forms of chronic hepatitis and response to interferon treatment. Clinical effectiveness of interferon alpha and beta treatment compared with chronic active viral hepatitis of various histologic grades].
    Cimino T, Leggieri A, De Rosa G, Bertucci R.
    Minerva Med; 1993 Dec 21; 84(12):681-5. PubMed ID: 8127458
    [Abstract] [Full Text] [Related]

  • 8. A pilot study of long-term weekly interferon-beta administration for chronic hepatitis B.
    Kagawa T, Morizane T, Saito H, Tsunematsu S, Tada S, Kumagai N, Tsuchimoto K, Sugiura H, Mukai M, Tsuchiya M.
    Am J Gastroenterol; 1993 Feb 21; 88(2):212-6. PubMed ID: 8424423
    [Abstract] [Full Text] [Related]

  • 9. Combination therapy with ARA-AMP and interferon of chronic active hepatitis B. Interim analysis of an ongoing study.
    Trépo C, Rougier P, Bizollon T, Poupon R, Zarski JP, Quinton A, Miguet JP, Causse X, Chossegros P, Chevallier M.
    J Hepatol; 1991 Feb 21; 13 Suppl 1():S3. PubMed ID: 1720439
    [No Abstract] [Full Text] [Related]

  • 10. [Liver, biliary tracts and human immunodeficiency virus infection. 1:q liver, HIV and hepatitis B, C and D viruses].
    Vuitton DA, Chossegros P, Bresson-Hadni S, Delfraissy JF, Kirn A, Marcellin P, Pol S, Saint-Paul MC.
    Gastroenterol Clin Biol; 1996 Feb 21; 20(3):269-80. PubMed ID: 8763066
    [No Abstract] [Full Text] [Related]

  • 11. The effect of interferon on activated peripheral blood T lymphocytes in patients with chronic active hepatitis B.
    Raptopoulou-Gigi M, Orphanou-Koumerkeridou H.
    Immunopharmacol Immunotoxicol; 1994 Nov 21; 16(4):577-88. PubMed ID: 7876462
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
    Sakai T, Shiraki K, Inoue H, Okano H, Deguchi M, Sugimoto K, Ohmori S, Murata K, Nakano T.
    Int J Mol Med; 2002 Aug 21; 10(2):201-4. PubMed ID: 12119559
    [Abstract] [Full Text] [Related]

  • 13. [Therapy of chronic hepatitis B, C and D with alpha-interferon].
    Niederau C.
    Fortschr Med; 1993 Feb 28; 111(6):35-7. PubMed ID: 8462911
    [No Abstract] [Full Text] [Related]

  • 14. Pilot study on the safety and efficacy of intravenous natural beta-interferon therapy in patients with chronic hepatitis C unresponsive to alpha-interferon.
    Mazzoran L, Grassi G, Giacca M, Gerini U, Baracetti S, Fanni-Canelles M, Zorat F, Pozzato G.
    Ital J Gastroenterol Hepatol; 1997 Aug 28; 29(4):338-42. PubMed ID: 9476188
    [Abstract] [Full Text] [Related]

  • 15. [Treatment with natural interferon (alfaferone) in clinical practice--our experience].
    Dybowska D, Halota W.
    Przegl Epidemiol; 2007 Aug 28; 61(1):17-22. PubMed ID: 17702434
    [Abstract] [Full Text] [Related]

  • 16. Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial.
    Janssen HL, Berk L, Heijtink RA, ten Kate FJ, Schalm SW.
    Hepatology; 1993 Mar 28; 17(3):383-8. PubMed ID: 8444411
    [Abstract] [Full Text] [Related]

  • 17. [The interferon therapy of patients with chronic viral hepatitis: the factors affecting the treatment results].
    Kokoreva LN, Zmyzgova AV, Shalygina NB.
    Ter Arkh; 1996 Mar 28; 68(2):10-4. PubMed ID: 8771646
    [Abstract] [Full Text] [Related]

  • 18. [Efficacy of adenine arabinoside (vidarabine) in the treatment of periarteritis nodosa associated with chronic active viral hepatitis B].
    Le Quellec A, Bories P, Bauret P, Piera S, Ouzan D, Trepo C, Michel H.
    Gastroenterol Clin Biol; 1986 Oct 28; 10(10):687-8. PubMed ID: 2878855
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
    Stancek D, Fuchsberger N, Oltman M, Schmeisser H, Kontsek P, Jahnová E, Hajnická V.
    Acta Virol; 2001 Oct 28; 45(5-6):287-92. PubMed ID: 12083327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.